Mechanism involved in the antiplatelet activity of naloxone in human platelets

Joen Rong Sheu, Wei Chun Hung, Ling Wen Lee, Pei Te Chang, Ya Chen Kan, Mao Hsiung Yen

研究成果: 雜誌貢獻文章同行評審

10 引文 斯高帕斯(Scopus)


In this study, naloxone was tested for its antiplatelet activity in human platelet suspensions. In platelet suspensions (4.5 x 108/ml), naloxone (0.1-0.5 mM) significantly inhibited platelet aggregation and ATP-release stimulated by various agonists (i.e., thrombin, collagen, U46619, and ADP). Furthermore, naloxone (0.5 and 0.8 mM) dose-dependently inhibited the intracellular free Ca2+ rise of Fura 2-AM loaded platelets stimulated by collagen. Additionally, naloxone (0.5 and 1.0 mM) did not influence the binding of FITC-triflavin to platelet glycoprotein (GP) IIb/IIIa complex. On the other hand, naloxone (0.5 mM) markedly decreased the fluorescence of platelet membranes tagged with diphenylhexatriene (DPH). In addition, naloxone (0.1-0.5 mM) did not significantly affect cyclic-AMP levels in human washed platelets. It is concluded that the antiplatelet activity of naloxone may possibly be due to the induction of conformational changes in the platelet membrane and the inhibition of the intracellular Ca2+ ([Ca2+]i) mobilization as well as the release reaction of platelets stimulated by agonists.

頁(從 - 到)12-16
期刊Biochemical and Biophysical Research Communications
出版狀態已發佈 - 2月 3 1997

ASJC Scopus subject areas

  • 生物化學
  • 生物物理學
  • 分子生物學


深入研究「Mechanism involved in the antiplatelet activity of naloxone in human platelets」主題。共同形成了獨特的指紋。